Table 3.
Clinical outcomes in the propensity score-matched cohort at three-year follow-up.
| Variables | All patients (n = 1,263) | Propensity matched sample (n = 486) | ||||||
|---|---|---|---|---|---|---|---|---|
| CAC group (n = 262) |
Non CAC group (n = 1,001) |
Odds ratio (95% CI) | P-value | CAC group (n = 243) |
Non CAC group (n = 243) |
Odds ratio (95% CI) | P–value | |
| TLF [n, (%)] | 25 (9.54) | 46 (4.60) | 2.421 (1.392, 4.341) | <0.001 | 24 (9.52) | 12 (4.94) | 2.080 (1.082, 3.998) | 0.034 |
| TLR [n, (%)] | 19 (7.25) | 27 (2.70) | 2.674 (1.139, 5.414) | <0.001 | 18 (7.41) | 7 (2.88) | 2.642 (1.206, 5.787) | 0.020 |
| MACE [n, (%)] | 32 (12.21) | 68 (6.79) | 1.942 (1.107, 3.263) | 0.003 | 30 (12.35) | 19 (7.82) | 1.665 (0.951, 2.916) | 0.079 |
| Cardiac death [n, (%)] | 5 (1.91) | 14 (1.40) | 1.424 (0.348, 5.763) | 0.578 | 5 (2.06) | 5 (2.06) | 0.995 (0.288, 3.436) | 0.993 |
| MI [n, (%)] | 4 (1.53) | 10 (1.00) | 1.457 (0.422, 4.977) | 0.725 | 3 (1.23) | 2 (0.82) | 1.505 (0.261, 8.689) | 0.652 |
| Any revascularization [n, (%)] | 34 (12.98) | 78 (7.79) | 1.863 (1.347, 3.122) | 0.010 | 31 (12.76) | 26 (9.67) | 1.256 (0.747, 2.111) | 0.738 |
TLF, Target Lesion Failure; TLR, Target Lesion Revascularization; MACE, Major Adverse Cardiac Events; MI, Myocardial Infarction.